A nurse's decease has been linked to her taking a weight-loss cause that was approved for usage connected the NHS.
Susan McGowan, 58, from Lanarkshire, died from multiple organ failure, septic daze and pancreatitis aft taking two low-dose injections of tirzepatide, known nether the marque sanction Mounjaro.
She took the jabs for a two-week play earlier her decease connected September 4, which is thought to beryllium the archetypal decease officially linked to cause successful the UK.
Earlier this week, the Danish shaper of famed weight-loss jab Ozempic revealed that ten Americans died and 100 were hospitalised aft taking pharmacy-made knockoffs of their drug.
Ms McGowan was a caregiver astatine University Hospital Monklands successful Airdrie, Scotland, for much than 3 decades and had often chatted with her friends astir her conflict to suffer weight.
Weight-loss jab Mounjaro was approved for usage by NHS Scotland by the Scottish Medicines Consortium successful June this year
She bought a medicine done a registered online pharmacy aft looking into Mounjaro and seeking aesculapian advice.
Just days aft taking the drug, which costs betwixt £150 and £200 for a four-week supply, Ms McGowan started having terrible tummy pains and went to A&E astatine the infirmary she worked at.
Although her colleagues fought to prevention her, she tragically passed distant with her niece Jade Campbell by her side.
Jade told the BBC: 'Susan had ever carried a wee spot of other value but determination were ne'er immoderate wellness concerns. She wasn't connected immoderate different medication. She was healthy.'
'Susan was specified a bubbly person. She was truly generous, she was truly benignant and she was the beingness of the enactment - a immense personality. They said she had the biggest laughter successful the hospital.'
In June, Scotland became the archetypal state successful the UK to approve Mounjaro, which was dubbed the 'King Kong' of obesity jabs.
The Scottish Medicines Consortium ruled this twelvemonth that Mounjaro could beryllium made disposable connected the NHS to radical to assistance them lose weight.
Mounjaro is the latest successful a enactment of slimming injections that person seen users shed immense amounts of weight, and is thought to beryllium 1 of the astir effective.
It volition cost the Scottish NHS £33.6million a year. The outgo of obesity to the NHS is estimated astatine £600million a year.
Mounjaro is the marque sanction of a cause called tirzepatide, and is given arsenic a play injection successful assorted strengths.
It is the latest of a caller procreation of jabs that assistance radical lose weight, akin to Ozempic and Wegovy which person besides precocious been approved by the SMC.
The drugs, known arsenic glucagon-like peptide-1 receptor agonists (GLP-1 RAs), suppress hunger by mimicking hormones indicating that the assemblage is full.
Mounjaro besides slows the transition of nutrient done the stomach.
Studies person recovered radical tin lose up to 20 per cent of their assemblage value implicit 36 weeks by taking Mounjaro.
The quality successful results led US diabetes adept Dr Julio Rosenstock to state Mounjaro 'King Kong' compared to 'the gorilla' of its rival Wegovy.
However radical mostly request to support taking the medicine successful bid to support their value loss.
Mounjaro was precocious approved by the SMC arsenic a attraction for benignant 2 diabetes arsenic it besides helps boost the accumulation of insulin, the hormone that regulates humor sugar.
The June ruling paved the mode for thousands of Scots without diabetes to person injections to assistance them suffer weight.
English (US) ·